CYTK
Cytokinetics Incorporated
$63.35
+$2.58(+4.25%)
47
Overall
40
Value
54
Tech
47
Quality
Market Cap
$7.36B
Volume
1.58M
52W Range
$29.31 - $69.33
Target Price
$79.79
EPS Estimates Overview
| Current Quarter | $-1.48 | Next Quarter | $-1.57 |
| Current Year | $-5.61 | Next Year | $-5.83 |
| QoQ Growth | -6.1% | YoY Growth | -3.9% |
| 3Y EPS CAGR | -23.4% | Target Price | $79.79 |
| Consensus | Buy | Upside | +26.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $63.35 | +4.2% | 1.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW